264 related articles for article (PubMed ID: 26544652)
1. Menopausal Hormone Therapy and Mortality: A Systematic Review and Meta-Analysis.
Benkhadra K; Mohammed K; Al Nofal A; Carranza Leon BG; Alahdab F; Faubion S; Montori VM; Abu Dabrh AM; Zúñiga Hernández JA; Prokop LJ; Murad MH
J Clin Endocrinol Metab; 2015 Nov; 100(11):4021-8. PubMed ID: 26544652
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy and women's health: An umbrella review.
Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
[TBL] [Abstract][Full Text] [Related]
3. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis.
Gu Y; Han F; Xue M; Wang M; Huang Y
BMC Womens Health; 2024 Jan; 24(1):60. PubMed ID: 38263123
[TBL] [Abstract][Full Text] [Related]
4. The effects of exogenous estrogen in women with SAR-CoV-2 infection: a systematic review and meta-analysis.
Sakulpaisal M; Sothornwit J; Somboonporn W
Hum Reprod; 2023 Jun; 38(6):1111-1123. PubMed ID: 37071891
[TBL] [Abstract][Full Text] [Related]
5. Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants.
Xu Z; Chung HF; Dobson AJ; Wilson LF; Hickey M; Mishra GD
Hum Reprod; 2022 Aug; 37(9):2175-2185. PubMed ID: 35690930
[TBL] [Abstract][Full Text] [Related]
6. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials.
Greiser CM; Greiser EM; Dören M
Hum Reprod Update; 2005; 11(6):561-73. PubMed ID: 16150812
[TBL] [Abstract][Full Text] [Related]
7. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis.
Asi N; Mohammed K; Haydour Q; Gionfriddo MR; Vargas OL; Prokop LJ; Faubion SS; Murad MH
Syst Rev; 2016 Jul; 5(1):121. PubMed ID: 27456847
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.
Stuenkel CA; Davis SR; Gompel A; Lumsden MA; Murad MH; Pinkerton JV; Santen RJ
J Clin Endocrinol Metab; 2015 Nov; 100(11):3975-4011. PubMed ID: 26444994
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations.
Nelson HD; Walker M; Zakher B; Mitchell J
Ann Intern Med; 2012 Jul; 157(2):104-13. PubMed ID: 22786830
[TBL] [Abstract][Full Text] [Related]
10. An update on menopausal hormone replacement therapy in women and cardiovascular disease.
Valdiviezo C; Lawson S; Ouyang P
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):148-55. PubMed ID: 23422240
[TBL] [Abstract][Full Text] [Related]
11. Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis.
Bontempo S; Yeganeh L; Giri R; Vincent AJ
Climacteric; 2024 Feb; 27(1):93-103. PubMed ID: 37933495
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Risk/Benefit Profile of MHT.
Villa P; Amar ID; Shachor M; Cipolla C; Ingravalle F; Scambia G
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31500138
[No Abstract] [Full Text] [Related]
13. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis.
Coronado PJ; Gómez A; Iglesias E; Fasero M; Baquedano L; Sánchez S; Ramírez-Polo I; de la Viuda E; Otero B; Llaneza P; Mendoza N; Lubián DM;
Menopause; 2024 Mar; 31(3):234-242. PubMed ID: 38385734
[TBL] [Abstract][Full Text] [Related]
14. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
[TBL] [Abstract][Full Text] [Related]
15. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
Yuk JS; Kim T; Cho H; Gwak G
Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
[TBL] [Abstract][Full Text] [Related]
18. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.
Harman SM
Fertil Steril; 2014 Apr; 101(4):887-97. PubMed ID: 24680648
[TBL] [Abstract][Full Text] [Related]
19. [Menopausal hormone therapy an cardiovascular risk. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Plu-Bureau G; Mounier-Vehier C
Gynecol Obstet Fertil Senol; 2021 May; 49(5):438-447. PubMed ID: 33757923
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.
Anagnostis EA
J Pharm Pract; 2012 Jun; 25(3):324-30. PubMed ID: 22550160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
